Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
7.07
+0.04 (0.57%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Grifols Employees
Grifols had 23,737 employees as of December 31, 2023. The number of employees decreased by 2,577 or -9.79% compared to the previous year.
Employees
23,737
Change (1Y)
-2,577
Growth (1Y)
-9.79%
Revenue / Employee
$314,572
Profits / Employee
$6,844
Market Cap
5.68B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 23,737 | -2,577 | -9.79% |
Dec 31, 2022 | 26,314 | 3,080 | 13.26% |
Dec 31, 2021 | 23,234 | -421 | -1.78% |
Dec 31, 2020 | 23,655 | -348 | -1.45% |
Dec 31, 2019 | 24,003 | 2,773 | 13.06% |
Dec 31, 2018 | 21,230 | 2,934 | 16.04% |
Dec 31, 2017 | 18,296 | 3,419 | 22.98% |
Dec 31, 2016 | 14,877 | 140 | 0.95% |
Dec 31, 2015 | 14,737 | 757 | 5.41% |
Dec 31, 2014 | 13,980 | 2,201 | 18.69% |
Dec 31, 2013 | 11,779 | 671 | 6.04% |
Dec 31, 2012 | 11,108 | -122 | -1.09% |
Dec 31, 2011 | 11,230 | 5,262 | 88.17% |
Dec 31, 2010 | 5,968 | -16 | -0.27% |
Dec 31, 2009 | 5,984 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
GRFS News
- 11 days ago - IBL International collaborates with Grifols on advanced biomarker panels - Business Wire
- 17 days ago - Brookfield resumes Grifols takeover talks, El Confidencial reports - Reuters
- 7 weeks ago - Grifols: Looking At The Longer-Term 2025-2027 Upside After No Sale - Seeking Alpha
- 7 weeks ago - Grifols expects to boost revenue and free cash flow, shares soar - Reuters
- 7 weeks ago - Grifols' sales rise over 10% in 2024, above target - Reuters
- 2 months ago - Blood Plasma Derivatives Market Insights and Forecast 2025-2030 - Grifols, SK Plasma, and Fusion Health Care Lead the Competition - GlobeNewsWire
- 3 months ago - Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease - GlobeNewsWire
- 3 months ago - Mason Capital complains about Grifols' transparency to Spanish regulator - Reuters